Benzotriazole

Benzotriazole

SCHEMBL14975700

N#Cc1cccc(N)c1.c1ccc2[nH]nnc2c1

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 2/20 0.44
MTOR P42345 1/20 0.44
PDK1 Q15118 1/20 0.44
ADORA2A P29274 2/20 0.40
IRAK4 Q9NWZ3 2/20 0.39
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
TP53 P04637 2/20 0.38
HSD17B10 Q99714 2/20 0.38
NPC1 O15118 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NTRK1 P04629 2/20 0.37
ABCG2 Q9UNQ0 2/20 0.36
AURKA O14965 1/20 0.36
ADORA1 P30542 1/20 0.36
MAPT P10636 2/20 0.35
MAP4K4 O95819 1/20 0.35
XDH P47989 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzotriazole SCHEMBL27662581 0.78 EGFR (0.35) KDM4EALDH1A1TP53HSD17B10NPC1
Benzotriazole SCHEMBL27770572 0.78 TSHR (0.44) PIK3CAMTORPDK1KDM4EALDH1A1
Benzotriazole SCHEMBL28258951 0.76 ALDH1A1 (0.39) KDM4EALDH1A1TP53HSD17B10NPC1
SCHEMBL29517490 0.76
Benzotriazole SCHEMBL9059391 0.76 ALDH1A1 (0.39) KDM4EALDH1A1TP53HSD17B10NPC1
SCHEMBL71478 0.76
Benzotriazole SCHEMBL27438561 0.76 ALDH1A1 (0.39) KDM4EALDH1A1TP53HSD17B10NPC1
Benzotriazole SCHEMBL343607 0.76 ALDH1A1 (0.39) KDM4EALDH1A1TP53HSD17B10NPC1
Benzotriazole SCHEMBL27864323 0.74 KDM4E (0.34) KDM4EALDH1A1TP53HSD17B10NPC1
Hydrochloric Acid SCHEMBL4380334 0.74 CYP3A4 (0.50) PIK3CAADORA2AIRAK4ALDH1A1NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140323418-A1 SELECTIVE KINASE INHIBITORS PORTOLA PHARMACEUTICALS, INC. (US) 2014-10-30 US disclosed
EP-2782580-A1 SELECTIVE KINASE INHIBITORS Portola Pharmaceuticals, Inc. (US) 2014-10-01 EP disclosed
WO-2013078468-A1 SELECTIVE KINASE INHIBITORS PORTOLA PHARMACEUTICALS, INC. (US) 2013-05-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140323418-A1 SELECTIVE KINASE INHIBITORS SYK, BTK, LCK PIK3CA 97/4885MTOR 388/4885PDK1 785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.